European Academy of Neurology guideline on trigeminal neuralgia

Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The Eur...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:European journal of neurology Ročník 26; číslo 6; s. 831 - 849
Hlavní autoři: Bendtsen, L., Zakrzewska, J. M., Abbott, J., Braschinsky, M., Di Stefano, G., Donnet, A., Eide, P. K., Leal, P. R. L., Maarbjerg, S., May, A., Nurmikko, T., Obermann, M., Jensen, T. S., Cruccu, G.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England John Wiley & Sons, Inc 01.06.2019
Témata:
Baclofen
Botulinum toxin
Botulinum toxin type A
Carbamazepine
Decision making
Decompression
Diagnosis
Gabapentin
guideline
Guidelines
Intravenous administration
Intravenous infusion
Lamotrigine
Lidocaine
Literature reviews
Magnetic resonance imaging
Management
Medical imaging
Medical treatment
Microvasculature
Neuralgia
Neurology
NMR
Nuclear magnetic resonance
Nursing
Oxcarbazepine
Pain
Patients
Pharmacology
Phenytoin
Reflexes
Sequences
Surgery
Trigeminal nerve
trigeminal neuralgia
management
trigeminal neuralgia
guideline
ISSN:1351-5101, 1468-1331, 1468-1331
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN. Methods A systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given. Results The use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high‐resolution sequences, should be performed as part of the work‐up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long‐term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add‐on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first‐line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support. Conclusions Compared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management. Click here for the corresponding questions to this CME article.
AbstractList Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN. Methods A systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given. Results The use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high‐resolution sequences, should be performed as part of the work‐up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long‐term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add‐on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first‐line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support. Conclusions Compared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management. Click here for the corresponding questions to this CME article.
Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN.BACKGROUND AND PURPOSETrigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN.A systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given.METHODSA systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given.The use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high-resolution sequences, should be performed as part of the work-up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long-term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add-on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first-line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support.RESULTSThe use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high-resolution sequences, should be performed as part of the work-up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long-term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add-on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first-line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support.Compared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management.CONCLUSIONSCompared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management.
Click here for the corresponding questions to this CME article.
Background and purposeTrigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN.MethodsA systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given.ResultsThe use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high‐resolution sequences, should be performed as part of the work‐up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long‐term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add‐on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first‐line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support.ConclusionsCompared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management.
Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN. A systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given. The use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high-resolution sequences, should be performed as part of the work-up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long-term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add-on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first-line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support. Compared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management.
Author Di Stefano, G.
May, A.
Braschinsky, M.
Obermann, M.
Nurmikko, T.
Abbott, J.
Leal, P. R. L.
Zakrzewska, J. M.
Eide, P. K.
Cruccu, G.
Bendtsen, L.
Donnet, A.
Jensen, T. S.
Maarbjerg, S.
Author_xml – sequence: 1
  givenname: L.
  orcidid: 0000-0002-4810-4998
  surname: Bendtsen
  fullname: Bendtsen, L.
  email: lars.bendtsen@regionh.dk
  organization: University of Copenhagen
– sequence: 2
  givenname: J. M.
  surname: Zakrzewska
  fullname: Zakrzewska, J. M.
  organization: UCLH NHS Foundation Trust
– sequence: 3
  givenname: J.
  surname: Abbott
  fullname: Abbott, J.
  organization: Trigeminal Neuralgia Association UK
– sequence: 4
  givenname: M.
  orcidid: 0000-0002-3457-0242
  surname: Braschinsky
  fullname: Braschinsky, M.
  organization: University of Tartu
– sequence: 5
  givenname: G.
  surname: Di Stefano
  fullname: Di Stefano, G.
  organization: Sapienza University
– sequence: 6
  givenname: A.
  surname: Donnet
  fullname: Donnet, A.
  organization: APHM
– sequence: 7
  givenname: P. K.
  surname: Eide
  fullname: Eide, P. K.
  organization: University of Oslo
– sequence: 8
  givenname: P. R. L.
  surname: Leal
  fullname: Leal, P. R. L.
  organization: University of Lyon 1
– sequence: 9
  givenname: S.
  surname: Maarbjerg
  fullname: Maarbjerg, S.
  organization: University of Copenhagen
– sequence: 10
  givenname: A.
  surname: May
  fullname: May, A.
  organization: Universitäts‐Krankenhaus Eppendorf
– sequence: 11
  givenname: T.
  surname: Nurmikko
  fullname: Nurmikko, T.
  organization: Walton Centre NHS Foundation Trust
– sequence: 12
  givenname: M.
  surname: Obermann
  fullname: Obermann, M.
  organization: Asklepios Hospitals Schildautal
– sequence: 13
  givenname: T. S.
  orcidid: 0000-0002-3487-6380
  surname: Jensen
  fullname: Jensen, T. S.
  organization: University of Aarhus
– sequence: 14
  givenname: G.
  orcidid: 0000-0003-1533-0902
  surname: Cruccu
  fullname: Cruccu, G.
  organization: Sapienza University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30860637$$D View this record in MEDLINE/PubMed
BookMark eNp90E1r3DAQBmBRUpqP9tA_UAy9tAcnM7Jk2acSwvYDQnppz2ZWGi8KsrSVbcL--6rdtIdAOxcN4plheM_FSUyRhXiNcImlrjjyJTa9hmfiDFXb1dg0eFL6RmOtEfBUnM_zPQBII-GFOG2ga6FtzJn4sFlz2jPF6tqS4-lQpbG64_IZ0u5Q7VbvOPjIVYrVkv2OJx8pVLEICjtPL8XzkcLMrx7fC_H94-bbzef69uunLzfXt7VVWkHdO-gVKWOItOt6GjtttUbH0rWyo9EwIepGgTG6g63tCR1a5cC2W5ajbC7Eu-PefU4_Vp6XYfKz5RAoclrnQWIPqkej2kLfPqH3ac3l6qIktkpCb7qi3jyqdTuxG_bZT5QPw59oCnh_BDanec48_iUIw6_YhxL78Dv2Yq-eWOsXWnyKSyYf_jfx4AMf_r162NxtjhM_AVejkS0
CitedBy_id crossref_primary_10_1016_j_coms_2021_09_002
crossref_primary_10_1016_j_monrhu_2021_05_001
crossref_primary_10_12688_f1000research_51845_2
crossref_primary_10_12688_f1000research_51845_3
crossref_primary_10_1177_08465371241311247
crossref_primary_10_3389_fsurg_2024_1517064
crossref_primary_10_1186_s12883_021_02197_6
crossref_primary_10_1186_s12883_024_03977_6
crossref_primary_10_36927_2079_0325_V32_is3_2024_1
crossref_primary_10_1016_j_ejphar_2021_174625
crossref_primary_10_1159_000543859
crossref_primary_10_3389_fneur_2024_1406602
crossref_primary_10_1016_j_clineuro_2025_108926
crossref_primary_10_1186_s10194_022_01488_8
crossref_primary_10_1177_03331024231191136
crossref_primary_10_1016_j_sdentj_2023_04_003
crossref_primary_10_1177_1744806920901890
crossref_primary_10_1155_2019_8685954
crossref_primary_10_1016_j_clineuro_2023_107710
crossref_primary_10_1111_head_14212
crossref_primary_10_1097_MD_0000000000040318
crossref_primary_10_4103__ANT_33_2_111_0091
crossref_primary_10_1007_s00330_024_10775_8
crossref_primary_10_1016_j_jns_2021_117430
crossref_primary_10_1007_s00701_023_05872_4
crossref_primary_10_1016_j_explore_2023_06_004
crossref_primary_10_3390_ijerph17197012
crossref_primary_10_25259_SNI_286_2024
crossref_primary_10_1016_j_wneu_2022_03_128
crossref_primary_10_1016_j_bjoms_2024_01_010
crossref_primary_10_1186_s12903_020_01227_y
crossref_primary_10_3390_jcm13082329
crossref_primary_10_1016_j_adaj_2023_10_004
crossref_primary_10_1186_s10194_021_01228_4
crossref_primary_10_1177_0333102419897623
crossref_primary_10_1212_CPJ_0000000000001075
crossref_primary_10_1016_j_bjae_2020_01_001
crossref_primary_10_3389_fneur_2020_00271
crossref_primary_10_1007_s11940_024_00795_6
crossref_primary_10_1093_brain_awac109
crossref_primary_10_1111_head_14321
crossref_primary_10_3390_ijms22126406
crossref_primary_10_1177_20494637231216352
crossref_primary_10_25259_SNI_634_2024
crossref_primary_10_22141_2224_0713_21_4_2025_1191
crossref_primary_10_3389_fsurg_2022_895394
crossref_primary_10_1227_neu_0000000000001877
crossref_primary_10_1227_neu_0000000000002967
crossref_primary_10_3390_toxins15090539
crossref_primary_10_1111_ene_15831
crossref_primary_10_1016_j_pbb_2025_174015
crossref_primary_10_1017_cjn_2023_52
crossref_primary_10_1007_s10143_025_03763_z
crossref_primary_10_1186_s10194_022_01489_7
crossref_primary_10_1007_s13760_019_01258_5
crossref_primary_10_3389_fneur_2024_1493274
crossref_primary_10_1038_s41380_020_0709_5
crossref_primary_10_3389_fneur_2024_1496656
crossref_primary_10_1212_CON_0000000000001415
crossref_primary_10_1177_2049463719892027
crossref_primary_10_1016_S1634_7072_21_44502_2
crossref_primary_10_1016_S1474_4422_22_00294_0
crossref_primary_10_3389_fneur_2022_1013216
crossref_primary_10_1007_s00701_023_05871_5
crossref_primary_10_1177_25158163221097349
crossref_primary_10_3389_fneur_2022_894006
crossref_primary_10_1007_s10143_023_02188_w
crossref_primary_10_1016_S1474_4422_22_00389_1
crossref_primary_10_7759_cureus_43645
crossref_primary_10_1111_head_13924
crossref_primary_10_1007_s43678_024_00785_2
crossref_primary_10_1186_s12896_023_00809_2
crossref_primary_10_36290_neu_2020_092
crossref_primary_10_1186_s12893_022_01469_3
crossref_primary_10_1177_03331024221094536
crossref_primary_10_1186_s12880_024_01239_y
crossref_primary_10_3389_fsurg_2022_843982
crossref_primary_10_1089_jpm_2020_0220
crossref_primary_10_1007_s40675_019_00152_z
crossref_primary_10_1016_j_adaj_2020_05_021
crossref_primary_10_2217_pgs_2019_0066
crossref_primary_10_1080_02688697_2025_2538484
crossref_primary_10_1097_MD_0000000000028631
crossref_primary_10_25259_SNI_262_2025
crossref_primary_10_1186_s10194_020_01156_9
crossref_primary_10_1111_ene_14248
crossref_primary_10_2147_JPR_S396680
crossref_primary_10_3390_brainsci12050583
crossref_primary_10_1038_s41572_024_00523_z
crossref_primary_10_1016_j_oooo_2021_03_003
crossref_primary_10_25259_SNI_562_2024
crossref_primary_10_7759_cureus_73110
crossref_primary_10_1177_03331024241273913
crossref_primary_10_1097_MD_0000000000041295
crossref_primary_10_7759_cureus_53061
crossref_primary_10_3390_biomedicines11082315
crossref_primary_10_1111_head_14414
crossref_primary_10_3389_fneur_2025_1614981
crossref_primary_10_1111_ene_70184
crossref_primary_10_1515_sjpain_2021_0045
crossref_primary_10_7759_cureus_48393
crossref_primary_10_1111_papr_13114
crossref_primary_10_3390_jcm14020528
crossref_primary_10_1177_03331024251322505
crossref_primary_10_7759_cureus_80456
crossref_primary_10_3389_fneur_2024_1362602
crossref_primary_10_1016_j_wneu_2024_03_162
crossref_primary_10_1007_s11916_024_01335_2
crossref_primary_10_1016_j_intimp_2023_110033
crossref_primary_10_3171_2022_8_FOCUS22370
crossref_primary_10_1177_17448069211016139
crossref_primary_10_33920_med_01_2507_10
crossref_primary_10_1186_s12894_021_00899_0
crossref_primary_10_4103_0028_3886_349723
crossref_primary_10_7759_cureus_76965
crossref_primary_10_1016_j_prro_2024_11_014
crossref_primary_10_1111_ner_13478
crossref_primary_10_1016_j_adaj_2025_03_010
crossref_primary_10_1016_j_jpain_2023_08_012
crossref_primary_10_3389_fneur_2023_1202426
crossref_primary_10_1186_s13104_020_05425_3
crossref_primary_10_1097_JCMA_0000000000000667
crossref_primary_10_3390_brainsci13040530
crossref_primary_10_1080_14737175_2021_1958677
crossref_primary_10_2147_JPR_S429713
crossref_primary_10_1038_s41598_022_24720_6
crossref_primary_10_1016_j_wneu_2022_07_014
crossref_primary_10_1016_j_toxicon_2023_107208
crossref_primary_10_1111_head_14316
crossref_primary_10_1007_s40263_020_00731_7
crossref_primary_10_1016_j_neuropharm_2024_109967
crossref_primary_10_1177_0333102420974356
crossref_primary_10_3166_dea_2020_0113
crossref_primary_10_2147_JPR_S449447
crossref_primary_10_1097_MD_0000000000041026
crossref_primary_10_3389_fsurg_2022_869223
crossref_primary_10_17650_2222_8721_2021_11_2_35_47
crossref_primary_10_1016_j_clineuro_2025_108909
crossref_primary_10_1097_j_pain_0000000000003590
crossref_primary_10_2147_JPR_S331036
crossref_primary_10_1159_000526053
crossref_primary_10_1007_s40265_023_01927_z
crossref_primary_10_3389_fneur_2024_1375587
crossref_primary_10_25259_SNI_394_2023
crossref_primary_10_1016_j_wneu_2023_08_102
crossref_primary_10_1227_neu_0000000000002476
crossref_primary_10_1080_01616412_2025_2511085
crossref_primary_10_1007_s10143_025_03559_1
crossref_primary_10_1155_2021_6676063
crossref_primary_10_46518_kjnmd_2023_15_1_8
crossref_primary_10_1093_pm_pnab228
crossref_primary_10_2147_JPR_S247182
crossref_primary_10_3389_fnins_2023_1265032
crossref_primary_10_1007_s00482_024_00806_0
crossref_primary_10_1111_ene_70053
crossref_primary_10_3389_fnana_2023_1276977
crossref_primary_10_3389_fneur_2022_946897
crossref_primary_10_1177_03331024221092435
crossref_primary_10_3389_fneur_2022_1090478
crossref_primary_10_1007_s00482_020_00496_4
crossref_primary_10_1155_2021_8817504
crossref_primary_10_1016_j_jocn_2023_01_002
crossref_primary_10_1016_j_nrleng_2023_04_005
crossref_primary_10_1007_s10072_023_06923_5
crossref_primary_10_1080_14656566_2020_1801635
crossref_primary_10_1177_03331024241292637
crossref_primary_10_1007_s11910_024_01387_2
crossref_primary_10_1016_j_radcr_2024_05_035
crossref_primary_10_12677_tcm_2025_147450
crossref_primary_10_1177_03331024231187160
crossref_primary_10_36927_2079_0325_V32_is4_2024_9
crossref_primary_10_3390_life15091457
crossref_primary_10_1016_j_otc_2022_03_001
crossref_primary_10_1007_s10143_024_03062_z
crossref_primary_10_1016_j_heliyon_2024_e26650
crossref_primary_10_3389_fsurg_2024_1378717
crossref_primary_10_1227_ons_0000000000000937
crossref_primary_10_1007_s10143_023_02221_y
crossref_primary_10_1016_j_cden_2022_01_003
crossref_primary_10_1097_SCS_0000000000011629
crossref_primary_10_1007_s12285_022_00373_2
crossref_primary_10_1016_j_mric_2024_04_005
crossref_primary_10_1177_10600280211003875
crossref_primary_10_1007_s12565_023_00740_8
crossref_primary_10_1016_j_bja_2023_04_021
crossref_primary_10_1093_brain_awaa331
crossref_primary_10_1080_14737175_2024_2365946
crossref_primary_10_17533_udea_iatreia_341
crossref_primary_10_7759_cureus_9226
crossref_primary_10_1177_03331024211027358
crossref_primary_10_3389_fneur_2022_930902
crossref_primary_10_1097_JS9_0000000000001110
crossref_primary_10_1177_01945998221087664
crossref_primary_10_1007_s10143_023_02124_y
crossref_primary_10_1227_ons_0000000000000362
crossref_primary_10_3390_jcm12186028
crossref_primary_10_1007_s40122_022_00377_x
crossref_primary_10_1007_s00482_024_00810_4
crossref_primary_10_1016_j_jocn_2021_09_040
crossref_primary_10_1007_s00701_024_06317_2
crossref_primary_10_1007_s13760_023_02310_1
crossref_primary_10_3390_pharmaceutics13040450
crossref_primary_10_1111_ors_12921
crossref_primary_10_1186_s40001_024_02205_8
crossref_primary_10_1212_CON_0000000000001488
crossref_primary_10_1177_0333102420949206
crossref_primary_10_4103_0028_3886_315975
crossref_primary_10_1007_s00701_020_04288_8
crossref_primary_10_1111_head_14043
crossref_primary_10_1186_s10194_023_01629_7
crossref_primary_10_1016_S1474_4422_25_00068_7
crossref_primary_10_3390_ijms23073604
crossref_primary_10_1177_0284185120983971
crossref_primary_10_1016_j_wneu_2024_07_094
crossref_primary_10_1080_07853890_2022_2117409
crossref_primary_10_12998_wjcc_v12_i22_5083
crossref_primary_10_1186_s10194_020_01134_1
crossref_primary_10_1007_s13760_024_02638_2
crossref_primary_10_1111_head_14505
crossref_primary_10_1159_000505727
crossref_primary_10_1016_j_ncl_2022_02_008
crossref_primary_10_1016_j_ncl_2023_12_011
crossref_primary_10_1080_14656566_2022_2087507
crossref_primary_10_1016_j_wneu_2022_09_025
crossref_primary_10_1016_j_bas_2021_100848
crossref_primary_10_1056_NEJMra1914484
crossref_primary_10_1111_eos_13029
crossref_primary_10_1136_jnnp_2024_335675
crossref_primary_10_1007_s42212_020_00279_z
crossref_primary_10_3390_brainsci13060858
crossref_primary_10_1097_j_pain_0000000000002349
crossref_primary_10_1212_CON_0000000000000962
crossref_primary_10_3389_fneur_2022_864061
crossref_primary_10_1177_25158163241268880
crossref_primary_10_20473_spmrj_v7i1_56458
crossref_primary_10_1002_ejp_2041
crossref_primary_10_1097_j_pain_0000000000002461
crossref_primary_10_1186_s12883_022_02906_9
crossref_primary_10_1016_j_wneu_2020_01_038
crossref_primary_10_1111_papr_13327
crossref_primary_10_1016_S1474_4422_20_30233_7
crossref_primary_10_1007_s11940_019_0583_0
crossref_primary_10_1093_pm_pnac120
crossref_primary_10_1097_j_pain_0000000000003428
crossref_primary_10_1111_ors_12475
crossref_primary_10_3390_biomedicines11102606
crossref_primary_10_1016_j_wneu_2025_123888
crossref_primary_10_1177_20494637211045877
crossref_primary_10_3390_life15030382
crossref_primary_10_1155_2024_8885274
crossref_primary_10_1016_j_neurol_2024_03_014
crossref_primary_10_1007_s40122_024_00587_5
crossref_primary_10_1016_j_wneu_2023_01_094
crossref_primary_10_1155_2022_3178154
crossref_primary_10_1016_j_wneu_2023_06_146
crossref_primary_10_1016_j_wneu_2024_11_082
crossref_primary_10_1111_head_15033
crossref_primary_10_3390_ctn9010016
crossref_primary_10_4103_0028_3886_315996
crossref_primary_10_1007_s00701_023_05849_3
crossref_primary_10_1093_cercor_bhad455
crossref_primary_10_1111_head_14183
crossref_primary_10_1111_papr_12910
crossref_primary_10_1227_ons_0000000000001438
crossref_primary_10_1515_sjpain_2021_0215
crossref_primary_10_3389_fphys_2025_1633028
crossref_primary_10_1016_j_wnsx_2024_100359
crossref_primary_10_3390_ph15101208
crossref_primary_10_1007_s00415_024_12433_x
crossref_primary_10_1002_jbio_202200301
crossref_primary_10_1002_cre2_882
crossref_primary_10_1016_j_jocn_2023_12_019
crossref_primary_10_1016_j_wneu_2023_10_095
crossref_primary_10_1007_s42399_020_00415_9
crossref_primary_10_1136_practneurol_2020_002782
crossref_primary_10_1002_ejp_1727
crossref_primary_10_1016_j_ctro_2024_100821
crossref_primary_10_1177_20503121211022197
crossref_primary_10_1111_head_13963
crossref_primary_10_29333_ejgm_16073
crossref_primary_10_1080_08869634_2020_1804233
crossref_primary_10_1016_j_npep_2023_102327
crossref_primary_10_2147_NDT_S407543
crossref_primary_10_1111_head_14373
crossref_primary_10_1097_j_pain_0000000000003054
crossref_primary_10_1186_s10194_022_01520_x
crossref_primary_10_3390_diagnostics11040613
crossref_primary_10_1186_s10194_021_01317_4
crossref_primary_10_1186_s10194_020_01149_8
crossref_primary_10_2147_TCRM_S373370
crossref_primary_10_1159_000538516
crossref_primary_10_31083_j_jin2106169
crossref_primary_10_3389_fneur_2023_1277654
crossref_primary_10_4103_ijpn_ijpn_9_21
crossref_primary_10_1007_s12035_022_02855_x
crossref_primary_10_1007_s13760_025_02729_8
crossref_primary_10_1186_s12883_025_04289_z
crossref_primary_10_1016_j_joms_2020_12_041
crossref_primary_10_1007_s00234_023_03155_4
crossref_primary_10_3171_2020_10_JNS202323
crossref_primary_10_3389_fneur_2023_1178335
crossref_primary_10_3892_mco_2024_2724
crossref_primary_10_1007_s10143_023_02089_y
crossref_primary_10_1007_s10143_024_02463_4
crossref_primary_10_1523_JNEUROSCI_2036_20_2021
crossref_primary_10_1016_j_clineuro_2025_108733
crossref_primary_10_1016_j_ncl_2022_09_001
crossref_primary_10_1016_j_radcr_2022_12_018
crossref_primary_10_1097_j_pain_0000000000002070
crossref_primary_10_7759_cureus_64235
crossref_primary_10_1007_s00701_023_05656_w
crossref_primary_10_1089_acu_2022_29207_cpl
crossref_primary_10_2217_pmt_2021_0001
crossref_primary_10_1016_j_jocn_2023_09_009
crossref_primary_10_3389_fsurg_2022_1024619
crossref_primary_10_1016_j_cden_2022_07_008
crossref_primary_10_1186_s10194_020_01198_z
crossref_primary_10_3389_fneur_2020_00716
crossref_primary_10_1016_j_jns_2021_120101
crossref_primary_10_1016_j_clineuro_2024_108466
crossref_primary_10_3390_medicina58050627
crossref_primary_10_1002_ejp_1941
crossref_primary_10_46563_2686_8997_2025_6_2_98_104
crossref_primary_10_1111_papr_70051
crossref_primary_10_3390_jcm13226890
crossref_primary_10_1080_01616412_2020_1794372
crossref_primary_10_1016_j_clinph_2024_12_025
crossref_primary_10_1016_j_neurol_2020_01_361
crossref_primary_10_1097_MD_0000000000039353
crossref_primary_10_1111_head_14952
crossref_primary_10_1016_j_brs_2025_06_013
crossref_primary_10_1155_2022_6735054
crossref_primary_10_1016_j_redare_2025_501668
crossref_primary_10_1227_ons_0000000000000831
crossref_primary_10_1371_journal_pone_0221110
crossref_primary_10_1007_s12663_021_01682_2
crossref_primary_10_1007_s40267_024_01087_4
crossref_primary_10_3389_fneur_2022_1018268
crossref_primary_10_1016_j_msard_2019_101461
crossref_primary_10_1016_j_nrleng_2021_03_010
crossref_primary_10_1007_s00701_025_06651_z
crossref_primary_10_1016_j_neurol_2024_04_002
crossref_primary_10_7759_cureus_61898
crossref_primary_10_1016_j_msard_2021_103472
crossref_primary_10_3389_fphar_2024_1461355
crossref_primary_10_1016_j_jocn_2022_08_005
crossref_primary_10_1016_j_disamonth_2021_101302
crossref_primary_10_1016_j_clineuro_2024_108695
crossref_primary_10_1177_1744806920980538
crossref_primary_10_1016_j_radcr_2025_06_100
crossref_primary_10_1007_s11916_024_01260_4
crossref_primary_10_1177_03331024231167130
crossref_primary_10_1016_j_wneu_2020_02_029
crossref_primary_10_1111_head_14144
crossref_primary_10_3389_fneur_2021_738032
crossref_primary_10_1007_s00701_021_05028_2
crossref_primary_10_1016_j_heliyon_2023_e19756
Cites_doi 10.1186/s10194-015-0548-y
10.1007/s11547-013-0928-9
10.1159/000008192
10.1007/s00701-011-1135-x
10.1227/01.NEU.0000159883.35957.E0
10.1186/s10194-015-0550-4
10.1016/j.wneu.2017.04.085
10.1007/s004150070157
10.1016/S0304-3959(97)00104-8
10.1136/jnnp.37.11.1225
10.1016/j.pain.2008.12.026
10.1159/000097925
10.1111/head.12791
10.1016/j.jocn.2009.02.028
10.3174/ajnr.A1409
10.1186/s10194-015-0563-z
10.1227/01.NEU.0000137656.59536.0E
10.1258/ar.2011.110195
10.1007/s00701-009-0588-7
10.1002/ejp.543
10.3171/2014.1.JNS131410
10.1111/ene.12818
10.1007/BF00887823
10.1111/j.1552-6569.2009.00378.x
10.1177/0333102417738202
10.1186/s10194-016-0651-8
10.1227/NEU.0b013e318212bafa
10.1212/WNL.0000000000002840
10.1001/archneur.1966.00470140019003
10.1186/1746-160X-4-11
10.1007/s10194-010-0198-z
10.1016/j.pain.2005.06.028
10.1007/s10194-011-0354-0
10.1007/s10072-005-0431-8
10.1097/j.pain.0000000000000160
10.1212/01.wnl.0000269670.30045.6b
10.1016/j.wneu.2018.01.141
10.1212/WNL.45.7.1294
10.1016/j.pain.2008.08.018
10.1007/s00330-011-2216-1
10.1007/s00701-015-2515-4
10.1136/jnnp.53.12.1034
10.1007/s00415-003-1032-1
10.1016/0168-5597(88)90069-X
10.1186/1129-2377-15-43
10.1016/S0304-3959(01)00406-7
10.1227/01.NEU.0000377861.14650.98
10.3340/jkns.2008.44.4.199
10.1016/j.ejrad.2007.10.010
10.1016/S0885-3924(01)00269-X
10.1111/j.1468-1331.2008.02185.x
10.3390/medicina47070055
10.1212/WNL.20.6.574
10.1093/brain/awu349
10.3171/JNS/2008/109/12/S25
10.1111/j.1533-2500.2006.00079.x
10.1212/WNL.55.10.1587
10.1016/S0885-3924(01)00275-5
10.2147/JPR.S110161
10.1177/1756285615583202
10.1186/s12883-014-0248-2
10.1136/bmjopen-2017-016670
10.1212/WNL.51.2.609
10.1016/j.pain.2014.04.020
10.1007/s002340050546
10.1111/pme.12046
10.3389/fnana.2015.00105
10.3171/2016.9.JNS16149
10.1212/WNL.45.6.1097
10.1212/WNL.56.12.1722
10.1097/00006123-200210000-00020
10.1007/BF00309988
10.2146/ajhp100636
10.1016/j.tripleo.2003.08.003
10.1097/j.pain.0000000000000853
10.1136/jnnp.29.3.265
10.1212/WNL.0000000000002720
10.1212/WNL.48.6.1714
10.1001/archneur.1968.00480020015001
10.1159/000075105
10.1111/j.1526-4610.1969.hed0901054.x
10.1212/01.wnl.0000191388.64530.8f
10.1177/0333102418783294
10.1016/S0090-3019(02)00993-X
10.1155/2014/853826
10.1016/j.ejpain.2008.06.001
10.1055/s-2008-1077076
10.3171/jns.1995.83.5.0799
10.1186/1129-2377-15-34
10.1136/pgmj.57.663.16
10.1007/s00701-017-3325-7
10.1111/papr.12406
10.1067/moe.2001.115130
10.1097/SCS.0000000000003481
10.1016/j.wneu.2017.12.147
10.1227/01.NEU.0000375491.81803.5D
10.1016/j.jocn.2014.11.028
10.1111/j.1600-0404.1970.tb05803.x
10.1016/j.pain.2007.02.009
ContentType Journal Article
Copyright 2019 EAN
2019 EAN.
Copyright © 2019 European Academy of Neurology
Copyright_xml – notice: 2019 EAN
– notice: 2019 EAN.
– notice: Copyright © 2019 European Academy of Neurology
DBID AAYXX
CITATION
NPM
7TK
7U7
C1K
K9.
7X8
DOI 10.1111/ene.13950
DatabaseName CrossRef
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
ProQuest Health & Medical Complete (Alumni)
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1468-1331
EndPage 849
ExternalDocumentID 30860637
10_1111_ene_13950
ENE13950
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
169
1OB
1OC
24P
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADPDF
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFRAH
AFWVQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F5P
FEDTE
FUBAC
FYBCS
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIG
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
TEORI
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AGQPQ
AGXDD
AIDQK
AIDYY
AIQQE
CITATION
GROUPED_DOAJ
O8X
PHGZM
WIN
NPM
7TK
7U7
C1K
K9.
7X8
ID FETCH-LOGICAL-c4540-9d094a477aa5d89af85c551de2d628af7ea11534077580bc9a1d1c4d0c6be2f23
IEDL.DBID DRFUL
ISICitedReferencesCount 395
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000476944800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1351-5101
1468-1331
IngestDate Thu Oct 02 09:21:47 EDT 2025
Sat Nov 29 14:35:20 EST 2025
Mon Jul 21 05:57:17 EDT 2025
Tue Nov 18 21:08:37 EST 2025
Sat Nov 29 05:12:44 EST 2025
Wed Jan 22 17:04:06 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords management
trigeminal neuralgia
guideline
Language English
License 2019 EAN.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4540-9d094a477aa5d89af85c551de2d628af7ea11534077580bc9a1d1c4d0c6be2f23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
ORCID 0000-0003-1533-0902
0000-0002-3457-0242
0000-0002-4810-4998
0000-0002-3487-6380
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.13950
PMID 30860637
PQID 2216420978
PQPubID 1066358
PageCount 19
ParticipantIDs proquest_miscellaneous_2190491746
proquest_journals_2216420978
pubmed_primary_30860637
crossref_primary_10_1111_ene_13950
crossref_citationtrail_10_1111_ene_13950
wiley_primary_10_1111_ene_13950_ENE13950
PublicationCentury 2000
PublicationDate June 2019
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: June 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle European journal of neurology
PublicationTitleAlternate Eur J Neurol
PublicationYear 2019
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
References 2010; 11
2002; 17
1990; 53
2002; 95
1997; 48
2011; 61
2008; 109
2011; 52
2003; 59
1988; 71
2017; 158
2012; 11
2017; 159
2018; 39
2010; 20
2009; 13
2015; 138
2000; 247
2013; 118
2014; 15
1970; 20
2011; 68
2014; 19
2011; 69
1995; 242
2010; 3
2001; 56
2014; 120
2018; 38
2009; 16
2007; 69
2009; 69
2005; 117
2014; 2014
2014; 155
2016; 17
2016; 16
2001; 20
2001; 21
2004; 55
2018; 111
1995; 45
2018; 112
2008; 44
1994; 17
2007; 85
2016; 9
2001; 92
2002; 58
2017; 7
1966; 15
2018; 128
2002; 51
2000; 44
2011; 12
2008; 4
2005; 26
1998; 40
2017; 9
2008; 140
2011; 153
1969; 9
2010; 67
1966; 29
2014; 4
1968; 19
2013; 14
2006; 66
2000; 55
2007; 131
2016; 87
2008; 69
2016; 86
2010; 152
2011; 21
1998; 51
1974; 37
2015; 16
2015; 19
2003; 81
2017; 28
2003; 250
2008; 15
2006; 6
1983; 39
2015; 9
2015; 8
2016; 56
2004; 97
1995; 83
2009; 30
1997; 73
2015; 157
2015; 156
2015; 22
2009; 143
1981; 57
2011; 47
2017; 103
2005; 56
1970; 46
e_1_2_11_70_1
e_1_2_11_93_1
e_1_2_11_32_1
e_1_2_11_55_1
e_1_2_11_78_1
e_1_2_11_36_1
e_1_2_11_51_1
e_1_2_11_74_1
e_1_2_11_97_1
e_1_2_11_13_1
e_1_2_11_29_1
e_1_2_11_4_1
e_1_2_11_106_1
e_1_2_11_48_1
e_1_2_11_81_1
e_1_2_11_20_1
e_1_2_11_66_1
e_1_2_11_47_1
e_1_2_11_89_1
e_1_2_11_8_1
e_1_2_11_43_1
e_1_2_11_85_1
Williams AC (e_1_2_11_107_1) 2012; 11
e_1_2_11_59_1
e_1_2_11_50_1
e_1_2_11_92_1
e_1_2_11_31_1
e_1_2_11_77_1
e_1_2_11_58_1
e_1_2_11_35_1
e_1_2_11_73_1
Yameen F (e_1_2_11_102_1) 2011; 61
e_1_2_11_12_1
e_1_2_11_96_1
e_1_2_11_103_1
e_1_2_11_28_1
e_1_2_11_5_1
Berger I (e_1_2_11_83_1) 2017; 9
e_1_2_11_61_1
e_1_2_11_80_1
e_1_2_11_46_1
e_1_2_11_69_1
e_1_2_11_88_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_65_1
e_1_2_11_84_1
e_1_2_11_16_1
e_1_2_11_39_1
e_1_2_11_72_1
e_1_2_11_91_1
e_1_2_11_30_1
e_1_2_11_57_1
e_1_2_11_99_1
e_1_2_11_34_1
e_1_2_11_53_1
e_1_2_11_76_1
e_1_2_11_95_1
e_1_2_11_11_1
e_1_2_11_6_1
e_1_2_11_104_1
e_1_2_11_27_1
e_1_2_11_2_1
e_1_2_11_100_1
Kimura J (e_1_2_11_17_1) 1983; 39
e_1_2_11_45_1
e_1_2_11_68_1
e_1_2_11_41_1
e_1_2_11_87_1
e_1_2_11_108_1
e_1_2_11_22_1
e_1_2_11_64_1
e_1_2_11_15_1
e_1_2_11_38_1
e_1_2_11_19_1
e_1_2_11_94_1
e_1_2_11_71_1
Mursch K (e_1_2_11_24_1) 2002; 17
e_1_2_11_90_1
e_1_2_11_10_1
e_1_2_11_56_1
e_1_2_11_79_1
e_1_2_11_14_1
e_1_2_11_52_1
e_1_2_11_98_1
e_1_2_11_33_1
e_1_2_11_75_1
e_1_2_11_7_1
e_1_2_11_105_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_49_1
Wiffen PJ (e_1_2_11_54_1) 2014; 4
e_1_2_11_101_1
Liebel JT (e_1_2_11_62_1) 2001; 20
e_1_2_11_82_1
Beydoun A (e_1_2_11_63_1) 2002; 58
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_67_1
e_1_2_11_25_1
e_1_2_11_40_1
e_1_2_11_86_1
Lemos L (e_1_2_11_60_1) 2010; 3
e_1_2_11_109_1
e_1_2_11_18_1
e_1_2_11_37_1
References_xml – volume: 56
  start-page: 1304
  year: 2005
  end-page: 1311
  article-title: Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia
  publication-title: Neurosurgery
– volume: 69
  start-page: 459
  year: 2009
  end-page: 463
  article-title: A single‐blinded pilot study assessing neurovascular contact by using high‐resolution MR imaging in patients with trigeminal neuralgia
  publication-title: Eur J Radiol
– volume: 9
  start-page: e1000
  year: 2017
  article-title: Microvascular decompression versus stereotactic radiosurgery for trigeminal neuralgia: a decision analysis
  publication-title: Cureus
– volume: 143
  start-page: 186
  year: 2009
  end-page: 191
  article-title: Trigeminal neuralgia and pain related to multiple sclerosis
  publication-title: Pain
– volume: 92
  start-page: 424
  year: 2001
  end-page: 429
  article-title: The importance of routine magnetic resonance imaging in trigeminal neuralgia diagnosis
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 103
  start-page: 757
  year: 2017
  end-page: 767
  article-title: Meta‐analysis on safety and efficacy of microsurgical and radiosurgical treatment of trigeminal neuralgia
  publication-title: World Neurosurg
– volume: 16
  start-page: 66
  year: 2015
  article-title: Trigeminal neuralgia – a coherent cross‐specialty management program
  publication-title: J Headache Pain
– volume: 40
  start-page: 88
  year: 1998
  end-page: 95
  article-title: Sensitivity and specificity of MRA in the diagnosis of neurovascular compression in patients with trigeminal neuralgia. A correlation of MRA and surgical findings
  publication-title: Neuroradiology
– volume: 51
  start-page: 609
  year: 1998
  end-page: 611
  article-title: An open‐label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients
  publication-title: Neurology
– volume: 158
  start-page: 1166
  year: 2017
  end-page: 1174
  article-title: Evaluating the impact of trigeminal neuralgia
  publication-title: Pain
– volume: 7
  start-page: e016670
  year: 2017
  article-title: Non‐pharmacological self‐management for people living with migraine or tension‐type headache: a systematic review including analysis of intervention components
  publication-title: BMJ Open
– volume: 39
  start-page: 197
  year: 2018
  end-page: 208
  article-title: Prognostic factors for outcome of microvascular decompression in trigeminal neuralgia: a prospective systematic study using independent assessors
  publication-title: Cephalalgia
– volume: 59
  start-page: 93
  year: 2003
  end-page: 99
  article-title: Demonstration of neurovascular compression in trigeminal neuralgia and hemifacial spasm with magnetic resonance imaging: comparison with surgical findings in 60 consecutive cases
  publication-title: Surg Neurol
– volume: 61
  start-page: 437
  year: 2011
  end-page: 439
  article-title: Efficacy of transcutaneous electrical nerve stimulation and its different modes in patients with trigeminal neuralgia
  publication-title: J Pak Med Assoc
– volume: 242
  start-page: 93
  year: 1995
  end-page: 98
  article-title: The significance of three‐dimensional MR‐defined neurovascular compression for the pathogenesis of trigeminal neuralgia
  publication-title: J Neurol
– volume: 86
  start-page: 2094
  year: 2016
  end-page: 2099
  article-title: A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis
  publication-title: Neurology
– volume: 11
  start-page: 241
  year: 2010
  end-page: 246
  article-title: Evaluation of the pathophysiology of classical trigeminal neuralgia by blink reflex study and current perception threshold testing
  publication-title: J Headache Pain
– volume: 3
  start-page: 201
  year: 2010
  end-page: 212
  article-title: Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia
  publication-title: J Pain Res
– volume: 20
  start-page: 345
  year: 2010
  end-page: 349
  article-title: Predicting the outcome of microvascular decompression for trigeminal neuralgia using magnetic resonance tomographic angiography
  publication-title: J Neuroimaging
– volume: 22
  start-page: 1505
  year: 2015
  end-page: 1510
  article-title: Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces
  publication-title: Eur J Neurol
– volume: 155
  start-page: 1464
  year: 2014
  end-page: 1471
  article-title: Magnetic resonance imaging contribution for diagnosing symptomatic neurovascular contact in classical trigeminal neuralgia: a blinded case–control study and meta‐analysis
  publication-title: Pain
– volume: 15
  start-page: 34
  year: 2014
  article-title: Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
  publication-title: J Headache Pain
– volume: 128
  start-page: 68
  year: 2018
  end-page: 77
  article-title: Prospective comparison of long‐term pain relief rates after first‐time microvascular decompression and stereotactic radiosurgery for trigeminal neuralgia
  publication-title: J Neurosurg
– volume: 138
  start-page: 311
  year: 2015
  end-page: 319
  article-title: Significance of neurovascular contact in classical trigeminal neuralgia
  publication-title: Brain
– volume: 30
  start-page: 603
  year: 2009
  end-page: 607
  article-title: Severity analysis of neurovascular contact in patients with trigeminal neuralgia: assessment with the inner view of the 3D MR cisternogram and angiogram fusion imaging
  publication-title: AJNR Am J Neuroradiol
– volume: 17
  start-page: 51
  year: 1994
  end-page: 57
  article-title: Trigeminal neuralgia: differentiation between intracranial mass lesions and ordinary vascular compression as causative lesions
  publication-title: Neurosurg Rev
– volume: 9
  start-page: 535
  year: 2016
  end-page: 542
  article-title: Efficacy of stereotactic gamma knife surgery and microvascular decompression in the treatment of primary trigeminal neuralgia: a retrospective study of 220 cases from a single center
  publication-title: J Pain Res
– volume: 9
  start-page: 105
  year: 2015
  article-title: Differential myelinated and unmyelinated sensory and autonomic skin nerve fiber involvement in patients with ophthalmic postherpetic neuralgia
  publication-title: Front Neuroanat
– volume: 69
  start-page: 170
  year: 2008
  end-page: 174
  article-title: Long‐term results of 405 refractory trigeminal neuralgia surgeries in 256 patients
  publication-title: Zentralbl Neurochir
– volume: 21
  start-page: 506
  year: 2001
  end-page: 510
  article-title: Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis
  publication-title: J Pain Symptom Manage
– volume: 66
  start-page: 139
  year: 2006
  end-page: 141
  article-title: Diagnostic accuracy of trigeminal reflex testing in trigeminal neuralgia
  publication-title: Neurology
– volume: 9
  start-page: 54
  year: 1969
  end-page: 57
  article-title: A four year double‐blind study of tegretol in facial pain
  publication-title: Headache
– volume: 37
  start-page: 1225
  year: 1974
  end-page: 1230
  article-title: Electromyographic and reflex study in idiopathic and symptomatic trigeminal neuralgias: latency of the jaw and blink reflexes
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 4
  start-page: CD005451
  year: 2014
  article-title: Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
  publication-title: Cochrane Database Syst Rev
– volume: 17
  start-page: 63
  year: 2016
  article-title: Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta‐analysis of randomized controlled trials
  publication-title: J Headache Pain
– volume: 4
  start-page: 11
  year: 2008
  end-page: 14
  article-title: Perioperative and long‐term operative outcomes after surgery for trigeminal neuralgia: microvascular decompression vs percutaneous balloon ablation
  publication-title: Head Face Med
– volume: 45
  start-page: 1294
  year: 1995
  end-page: 1296
  article-title: Trigeminal neuralgia in multiple sclerosis
  publication-title: Neurology
– volume: 44
  start-page: 45
  year: 2000
  end-page: 48
  article-title: Low‐dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis
  publication-title: Eur Neurol
– volume: 56
  start-page: 1035
  year: 2016
  end-page: 1039
  article-title: Botulinum toxin as monotherapy in symptomatic trigeminal neuralgia
  publication-title: Headache
– volume: 14
  start-page: 430
  year: 2013
  end-page: 435
  article-title: Pulsed and conventional radiofrequency treatment: which is effective for dental procedure‐related symptomatic trigeminal neuralgia?
  publication-title: Pain Med
– volume: 20
  start-page: 574
  year: 1970
  end-page: 583
  article-title: Electrodiagnostic study of trigeminal nerve. Orbicularis oculi reflex and masseter reflex in trigeminal neuralgia, paratrigeminal syndrome, and other lesions of the trigeminal nerve
  publication-title: Neurology
– volume: 22
  start-page: 818
  year: 2015
  end-page: 822
  article-title: Long term efficacy and patient satisfaction of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia
  publication-title: J Clin Neurosci
– volume: 153
  start-page: 2377
  year: 2011
  end-page: 2381
  article-title: Preoperative MRI/MRA for microvascular decompression in trigeminal neuralgia: consecutive series of 67 patients
  publication-title: Acta Neurochir (Wien)
– volume: 28
  start-page: 256
  year: 2017
  end-page: 258
  article-title: Symptomatic trigeminal neuralgia caused by cerebellopontine angle tumors
  publication-title: J Craniofac Surg
– volume: 15
  start-page: 43
  year: 2014
  article-title: Therapeutic effect of botulinum toxin‐A in 88 patients with trigeminal neuralgia with 14‐month follow‐up
  publication-title: J Headache Pain
– volume: 46
  start-page: 385
  year: 1970
  end-page: 408
  article-title: Facial pain treated with carbamazepin (Tegretol)
  publication-title: Acta Neurol Scand
– volume: 117
  start-page: 349
  year: 2005
  end-page: 357
  article-title: Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain
  publication-title: Pain
– volume: 19
  start-page: 129
  year: 1968
  end-page: 136
  article-title: Carbamazepine in the treatment of neuralgia
  publication-title: Arch Neurol
– volume: 67
  start-page: 749
  year: 2010
  end-page: 753
  article-title: The effect of microvascular decompression in patients with multiple sclerosis and trigeminal neuralgia
  publication-title: Neurosurgery
– volume: 111
  start-page: 291
  year: 2018
  end-page: 306
  article-title: A systematic review of the management of trigeminal neuralgia in patients with multiple sclerosis
  publication-title: World Neurosurg
– volume: 250
  start-page: 542
  year: 2003
  end-page: 545
  article-title: Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis
  publication-title: J Neurol
– volume: 19
  start-page: 248
  year: 2014
  article-title: Trigeminal isolated sensory neuropathy (TISN) and FOSMN syndrome: despite a dissimilar disease course do they share common pathophysiological mechanisms?
  publication-title: BMC Neurol
– volume: 247
  start-page: 556
  year: 2000
  end-page: 558
  article-title: Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis
  publication-title: J Neurol
– volume: 131
  start-page: 302
  year: 2007
  end-page: 310
  article-title: Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions
  publication-title: Pain
– volume: 140
  start-page: 405
  year: 2008
  end-page: 410
  article-title: Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study
  publication-title: Pain
– volume: 53
  start-page: 1034
  year: 1990
  end-page: 1042
  article-title: Idiopathic and symptomatic trigeminal pain
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 44
  start-page: 199
  year: 2008
  end-page: 204
  article-title: The treatment outcome of elderly patients with idiopathic trigeminal neuralgia: micro‐vascular decompression versus gamma knife radiosurgery
  publication-title: J Korean Neurosurg Soc
– volume: 13
  start-page: 486
  year: 2009
  end-page: 491
  article-title: Patient led conferences – who attends, are their expectations met and do they vary in three different countries?
  publication-title: Eur J Pain
– volume: 87
  start-page: 220
  year: 2016
  end-page: 228
  article-title: Trigeminal neuralgia: new classification and diagnostic grading for practice and research
  publication-title: Neurology
– volume: 8
  start-page: 187
  year: 2015
  end-page: 188
  article-title: Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review
  publication-title: Ther Adv Neurol Disord
– volume: 57
  start-page: 16
  year: 1981
  end-page: 18
  article-title: Long‐term treatment of trigeminal neuralgia with carbamazepine
  publication-title: Postgrad Med J
– volume: 67
  start-page: 633
  year: 2010
  end-page: 638
  article-title: Prospective comparison of posterior fossa exploration and stereotactic radiosurgery dorsal root entry zone target as primary surgery for patients with idiopathic trigeminal neuralgia
  publication-title: Neurosurgery
– volume: 17
  start-page: 133
  year: 2002
  end-page: 136
  article-title: Trigeminal evoked potentials and sensory deficits in atypical facial pain – a comparison with results in trigeminal neuralgia
  publication-title: Funct Neurol
– volume: 15
  start-page: 1013
  year: 2008
  end-page: 1028
  article-title: AAN‐EFNS guidelines on trigeminal neuralgia management
  publication-title: Eur J Neurol
– volume: 19
  start-page: 253
  year: 2015
  end-page: 259
  article-title: Trigeminal laser‐evoked potentials: a neurophysiological tool to detect post‐surgical outcome in trigeminovascular contact neuralgia
  publication-title: Eur J Pain
– volume: 39
  start-page: 773
  year: 1983
  end-page: 786
  article-title: Clinical uses of the electrically elicited blink reflex
  publication-title: Adv Neurol
– volume: 95
  start-page: 259
  year: 2002
  end-page: 266
  article-title: Long‐term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia
  publication-title: Pain
– volume: 55
  start-page: 1587
  year: 2000
  end-page: 1588
  article-title: Topiramate relieves refractory trigeminal neuralgia in MS patients
  publication-title: Neurology
– volume: 12
  start-page: 485
  year: 2011
  end-page: 488
  article-title: Iatrogenic damage to the mandibular nerves as assessed by the masseter inhibitory reflex
  publication-title: J Headache Pain
– volume: 157
  start-page: 1925
  year: 2015
  end-page: 1933
  article-title: Diagnosis, medication, and surgical management for patients with trigeminal neuralgia: a qualitative study
  publication-title: Acta Neurochir (Wien)
– volume: 97
  start-page: 18
  year: 2004
  end-page: 22
  article-title: Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 69
  start-page: 835
  year: 2007
  end-page: 841
  article-title: Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia
  publication-title: Neurology
– volume: 120
  start-page: 1048
  year: 2014
  end-page: 1054
  article-title: Trigeminal neuralgia occurs and recurs in the absence of neurovascular compression
  publication-title: J Neurosurg
– volume: 55
  start-page: 830
  year: 2004
  end-page: 838
  article-title: Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis
  publication-title: Neurosurgery
– volume: 109
  start-page: 160
  year: 2008
  end-page: 172
  article-title: A prospective cohort study of microvascular decompression and gamma knife surgery in patients with trigeminal neuralgia
  publication-title: J Neurosurg
– volume: 85
  start-page: 94
  year: 2007
  end-page: 98
  article-title: Microvascular decompression vs. gamma knife radiosurgery for typical trigeminal neuralgia: preliminary findings
  publication-title: Stereotact Funct Neurosurg
– volume: 21
  start-page: 367
  year: 2001
  end-page: 368
  article-title: Topiramate relieves idiopathic and symptomatic trigeminal neuralgia
  publication-title: J Pain Symptom Manage
– volume: 45
  start-page: 1097
  year: 1995
  end-page: 1100
  article-title: Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue
  publication-title: Neurology
– volume: 118
  start-page: 1045
  year: 2013
  end-page: 1054
  article-title: Advanced virtual magnetic resonance imaging (MRI) techniques in neurovascular conflict: bidimensional image fusion and virtual cisternography
  publication-title: Radiol Med
– volume: 156
  start-page: 1003
  year: 2015
  end-page: 1007
  article-title: A classification of chronic pain for ICD‐11
  publication-title: Pain
– volume: 51
  start-page: 956
  year: 2002
  end-page: 961
  article-title: Preoperative evaluation of neurovascular compression in patients with trigeminal neuralgia by use of three‐dimensional reconstruction from two types of high‐resolution magnetic resonance imaging
  publication-title: Neurosurgery
– volume: 29
  start-page: 265
  year: 1966
  end-page: 267
  article-title: Clinical trial of carbazepine (tegretol) in trigeminal neuralgia
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 21
  start-page: 2633
  year: 2011
  end-page: 2639
  article-title: Trigeminal neuralgia: assessment with T2 VISTA and FLAIR VISTA fusion imaging
  publication-title: Eur Radiol
– volume: 68
  start-page: 2059
  year: 2011
  end-page: 2061
  article-title: Treatment of refractory trigeminal neuralgia with intravenous phenytoin
  publication-title: Am J Health Syst Pharm
– volume: 38
  start-page: 1
  year: 2018
  end-page: 211
  article-title: Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
  publication-title: Cephalalgia
– volume: 16
  start-page: 563
  year: 2015
  article-title: Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)
  publication-title: J Headache Pain
– volume: 16
  start-page: 1555
  year: 2009
  end-page: 1559
  article-title: Enhanced three‐dimensional fast spoiled gradient recalled MRI combined with magnetic resonance angiography for preoperative assessment of patients with trigeminal neuralgia
  publication-title: J Clin Neurosci
– volume: 48
  start-page: 1714
  year: 1997
  end-page: 1717
  article-title: Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia
  publication-title: Neurology
– volume: 159
  start-page: 2127
  year: 2017
  end-page: 2135
  article-title: Long‐term outcomes of microvascular decompression and gamma knife surgery for trigeminal neuralgia: a retrospective comparison study
  publication-title: Acta Neurochir (Wien)
– volume: 71
  start-page: 114
  year: 1988
  end-page: 124
  article-title: Early trigeminal evoked potentials in tumours of the base of the skull and trigeminal neuralgia
  publication-title: Electroencephalogr Clin Neurophysiol
– volume: 15
  start-page: 129
  year: 1966
  end-page: 136
  article-title: Controlled sequential trials of carbamazepine in trigeminal neuralgia
  publication-title: Arch Neurol
– volume: 58
  start-page: 02
  issue: suppl. 3
  year: 2002
  end-page: 08
  article-title: Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta‐analysis of three double blind comparative trials
  publication-title: Neurology
– volume: 52
  start-page: 894
  year: 2011
  end-page: 898
  article-title: Preoperative evaluation of neurovascular relationship by using contrast‐enhanced and unenhanced 3D time‐of‐flight MR angiography in patients with trigeminal neuralgia
  publication-title: Acta Radiol
– volume: 16
  start-page: 64
  year: 2015
  article-title: Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population‐based retrospective cohort study
  publication-title: J Headache Pain
– volume: 26
  start-page: 150
  issue: Suppl. 2
  year: 2005
  end-page: 151
  article-title: A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis
  publication-title: Neurol Sci
– volume: 56
  start-page: 1722
  year: 2001
  end-page: 1726
  article-title: Small‐fiber dysfunction in trigeminal neuralgia: carbamazepine effect on laser‐evoked potentials
  publication-title: Neurology
– volume: 2014
  start-page: 853826
  year: 2014
  article-title: The effect of intravenous lidocaine on trigeminal neuralgia: a randomized double blind placebo controlled trial
  publication-title: ISRN Pain
– volume: 16
  start-page: 1083
  year: 2016
  end-page: 1091
  article-title: Efficacy and safety of gabapentin vs. carbamazepine in the treatment of trigeminal neuralgia: a meta‐analysis
  publication-title: Pain Pract
– volume: 81
  start-page: 57
  year: 2003
  end-page: 64
  article-title: Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis
  publication-title: Stereotact Funct Neurosurg
– volume: 11
  start-page: CD007407
  year: 2012
  article-title: Psychological therapies for the management of chronic pain (excluding headache) in adults
  publication-title: Cochrane Database Syst Rev
– volume: 112
  start-page: e732
  year: 2018
  end-page: e746
  article-title: Pain‐free outcomes and durability of surgical intervention for trigeminal neuralgia: a comparison of gamma knife and microvascular decompression
  publication-title: World Neurosurg
– volume: 20
  start-page: 461
  year: 2001
  end-page: 465
  article-title: Oxcarbazepine in der Behandlung der Trigeminusneuralgie
  publication-title: Nervenheilkunde
– volume: 73
  start-page: 223
  year: 1997
  end-page: 230
  article-title: Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double‐blind placebo controlled crossover trial
  publication-title: Pain
– volume: 47
  start-page: 386
  year: 2011
  end-page: 392
  article-title: Associations between chronic pain and depressive symptoms in patients with trigeminal neuralgia
  publication-title: Medicina (Kaunas)
– volume: 6
  start-page: 153
  year: 2006
  end-page: 160
  article-title: Patient burden of trigeminal neuralgia: results from a cross‐sectional survey of health state impairment and treatment patterns in six European countries
  publication-title: Pain Pract
– volume: 83
  start-page: 799
  year: 1995
  end-page: 805
  article-title: Demonstration of neurovascular compression in trigeminal neuralgia with magnetic resonance imaging. Comparison with surgical findings in 52 consecutive operative cases
  publication-title: J Neurosurg
– volume: 152
  start-page: 817
  year: 2010
  end-page: 825
  article-title: Preoperative demonstration of the neurovascular compression characteristics with special emphasis on the degree of compression, using high‐resolution magnetic resonance imaging: a prospective study, with comparison to surgical findings, in 100 consecutive patients who underwent microvascular decompression for trigeminal neuralgia
  publication-title: Acta Neurochir (Wien)
– volume: 69
  start-page: 15
  year: 2011
  end-page: 25
  article-title: Visualization of vascular compression of the trigeminal nerve with high‐resolution 3T MRI: a prospective study comparing preoperative imaging analysis to surgical findings in 40 consecutive patients who underwent microvascular decompression for trigeminal neuralgia
  publication-title: Neurosurgery
– ident: e_1_2_11_103_1
  doi: 10.1186/s10194-015-0548-y
– ident: e_1_2_11_43_1
  doi: 10.1007/s11547-013-0928-9
– ident: e_1_2_11_90_1
  doi: 10.1159/000008192
– ident: e_1_2_11_39_1
  doi: 10.1007/s00701-011-1135-x
– ident: e_1_2_11_71_1
  doi: 10.1227/01.NEU.0000159883.35957.E0
– ident: e_1_2_11_73_1
  doi: 10.1186/s10194-015-0550-4
– ident: e_1_2_11_84_1
  doi: 10.1016/j.wneu.2017.04.085
– ident: e_1_2_11_89_1
  doi: 10.1007/s004150070157
– ident: e_1_2_11_65_1
  doi: 10.1016/S0304-3959(97)00104-8
– ident: e_1_2_11_16_1
  doi: 10.1136/jnnp.37.11.1225
– ident: e_1_2_11_19_1
  doi: 10.1016/j.pain.2008.12.026
– ident: e_1_2_11_75_1
  doi: 10.1159/000097925
– ident: e_1_2_11_97_1
  doi: 10.1111/head.12791
– ident: e_1_2_11_36_1
  doi: 10.1016/j.jocn.2009.02.028
– volume: 17
  start-page: 133
  year: 2002
  ident: e_1_2_11_24_1
  article-title: Trigeminal evoked potentials and sensory deficits in atypical facial pain – a comparison with results in trigeminal neuralgia
  publication-title: Funct Neurol
– ident: e_1_2_11_37_1
  doi: 10.3174/ajnr.A1409
– ident: e_1_2_11_64_1
  doi: 10.1186/s10194-015-0563-z
– ident: e_1_2_11_99_1
  doi: 10.1227/01.NEU.0000137656.59536.0E
– ident: e_1_2_11_38_1
  doi: 10.1258/ar.2011.110195
– ident: e_1_2_11_42_1
  doi: 10.1007/s00701-009-0588-7
– ident: e_1_2_11_20_1
  doi: 10.1002/ejp.543
– ident: e_1_2_11_40_1
  doi: 10.3171/2014.1.JNS131410
– ident: e_1_2_11_3_1
  doi: 10.1111/ene.12818
– ident: e_1_2_11_31_1
  doi: 10.1007/BF00887823
– ident: e_1_2_11_41_1
  doi: 10.1111/j.1552-6569.2009.00378.x
– ident: e_1_2_11_5_1
  doi: 10.1177/0333102417738202
– volume: 11
  start-page: CD007407
  year: 2012
  ident: e_1_2_11_107_1
  article-title: Psychological therapies for the management of chronic pain (excluding headache) in adults
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_11_67_1
  doi: 10.1186/s10194-016-0651-8
– ident: e_1_2_11_49_1
  doi: 10.1227/NEU.0b013e318212bafa
– ident: e_1_2_11_4_1
  doi: 10.1212/WNL.0000000000002840
– ident: e_1_2_11_58_1
  doi: 10.1001/archneur.1966.00470140019003
– ident: e_1_2_11_87_1
  doi: 10.1186/1746-160X-4-11
– ident: e_1_2_11_21_1
  doi: 10.1007/s10194-010-0198-z
– ident: e_1_2_11_29_1
  doi: 10.1016/j.pain.2005.06.028
– ident: e_1_2_11_28_1
  doi: 10.1007/s10194-011-0354-0
– ident: e_1_2_11_8_1
  doi: 10.1007/s10072-005-0431-8
– ident: e_1_2_11_6_1
  doi: 10.1097/j.pain.0000000000000160
– ident: e_1_2_11_25_1
  doi: 10.1212/01.wnl.0000269670.30045.6b
– ident: e_1_2_11_85_1
  doi: 10.1016/j.wneu.2018.01.141
– volume: 61
  start-page: 437
  year: 2011
  ident: e_1_2_11_102_1
  article-title: Efficacy of transcutaneous electrical nerve stimulation and its different modes in patients with trigeminal neuralgia
  publication-title: J Pak Med Assoc
– ident: e_1_2_11_11_1
  doi: 10.1212/WNL.45.7.1294
– ident: e_1_2_11_26_1
  doi: 10.1016/j.pain.2008.08.018
– ident: e_1_2_11_45_1
  doi: 10.1007/s00330-011-2216-1
– ident: e_1_2_11_106_1
  doi: 10.1007/s00701-015-2515-4
– ident: e_1_2_11_18_1
  doi: 10.1136/jnnp.53.12.1034
– ident: e_1_2_11_93_1
  doi: 10.1007/s00415-003-1032-1
– ident: e_1_2_11_22_1
  doi: 10.1016/0168-5597(88)90069-X
– ident: e_1_2_11_68_1
  doi: 10.1186/1129-2377-15-43
– ident: e_1_2_11_70_1
  doi: 10.1016/S0304-3959(01)00406-7
– ident: e_1_2_11_77_1
  doi: 10.1227/01.NEU.0000377861.14650.98
– volume: 3
  start-page: 201
  year: 2010
  ident: e_1_2_11_60_1
  article-title: Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia
  publication-title: J Pain Res
– ident: e_1_2_11_82_1
  doi: 10.3340/jkns.2008.44.4.199
– ident: e_1_2_11_48_1
  doi: 10.1016/j.ejrad.2007.10.010
– ident: e_1_2_11_52_1
  doi: 10.1016/S0885-3924(01)00269-X
– ident: e_1_2_11_2_1
  doi: 10.1111/j.1468-1331.2008.02185.x
– ident: e_1_2_11_104_1
  doi: 10.3390/medicina47070055
– ident: e_1_2_11_15_1
  doi: 10.1212/WNL.20.6.574
– ident: e_1_2_11_32_1
  doi: 10.1093/brain/awu349
– ident: e_1_2_11_76_1
  doi: 10.3171/JNS/2008/109/12/S25
– ident: e_1_2_11_105_1
  doi: 10.1111/j.1533-2500.2006.00079.x
– ident: e_1_2_11_96_1
  doi: 10.1212/WNL.55.10.1587
– ident: e_1_2_11_95_1
  doi: 10.1016/S0885-3924(01)00275-5
– ident: e_1_2_11_79_1
  doi: 10.2147/JPR.S110161
– ident: e_1_2_11_53_1
  doi: 10.1177/1756285615583202
– ident: e_1_2_11_30_1
  doi: 10.1186/s12883-014-0248-2
– ident: e_1_2_11_108_1
  doi: 10.1136/bmjopen-2017-016670
– ident: e_1_2_11_94_1
  doi: 10.1212/WNL.51.2.609
– ident: e_1_2_11_33_1
  doi: 10.1016/j.pain.2014.04.020
– ident: e_1_2_11_46_1
  doi: 10.1007/s002340050546
– ident: e_1_2_11_98_1
  doi: 10.1111/pme.12046
– ident: e_1_2_11_27_1
  doi: 10.3389/fnana.2015.00105
– ident: e_1_2_11_78_1
  doi: 10.3171/2016.9.JNS16149
– ident: e_1_2_11_92_1
  doi: 10.1212/WNL.45.6.1097
– ident: e_1_2_11_23_1
  doi: 10.1212/WNL.56.12.1722
– volume: 9
  start-page: e1000
  year: 2017
  ident: e_1_2_11_83_1
  article-title: Microvascular decompression versus stereotactic radiosurgery for trigeminal neuralgia: a decision analysis
  publication-title: Cureus
– ident: e_1_2_11_47_1
  doi: 10.1097/00006123-200210000-00020
– ident: e_1_2_11_12_1
  doi: 10.1007/BF00309988
– volume: 58
  start-page: 02
  issue: 3
  year: 2002
  ident: e_1_2_11_63_1
  article-title: Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta‐analysis of three double blind comparative trials
  publication-title: Neurology
– ident: e_1_2_11_51_1
  doi: 10.2146/ajhp100636
– ident: e_1_2_11_9_1
  doi: 10.1016/j.tripleo.2003.08.003
– ident: e_1_2_11_69_1
  doi: 10.1097/j.pain.0000000000000853
– ident: e_1_2_11_55_1
  doi: 10.1136/jnnp.29.3.265
– ident: e_1_2_11_14_1
  doi: 10.1212/WNL.0000000000002720
– volume: 4
  start-page: CD005451
  year: 2014
  ident: e_1_2_11_54_1
  article-title: Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_11_91_1
  doi: 10.1212/WNL.48.6.1714
– ident: e_1_2_11_56_1
  doi: 10.1001/archneur.1968.00480020015001
– ident: e_1_2_11_100_1
  doi: 10.1159/000075105
– ident: e_1_2_11_57_1
  doi: 10.1111/j.1526-4610.1969.hed0901054.x
– ident: e_1_2_11_7_1
  doi: 10.1212/01.wnl.0000191388.64530.8f
– volume: 39
  start-page: 773
  year: 1983
  ident: e_1_2_11_17_1
  article-title: Clinical uses of the electrically elicited blink reflex
  publication-title: Adv Neurol
– ident: e_1_2_11_34_1
  doi: 10.1177/0333102418783294
– ident: e_1_2_11_44_1
  doi: 10.1016/S0090-3019(02)00993-X
– volume: 20
  start-page: 461
  year: 2001
  ident: e_1_2_11_62_1
  article-title: Oxcarbazepine in der Behandlung der Trigeminusneuralgie
  publication-title: Nervenheilkunde
– ident: e_1_2_11_50_1
  doi: 10.1155/2014/853826
– ident: e_1_2_11_109_1
  doi: 10.1016/j.ejpain.2008.06.001
– ident: e_1_2_11_86_1
  doi: 10.1055/s-2008-1077076
– ident: e_1_2_11_35_1
  doi: 10.3171/jns.1995.83.5.0799
– ident: e_1_2_11_74_1
  doi: 10.1186/1129-2377-15-34
– ident: e_1_2_11_61_1
  doi: 10.1136/pgmj.57.663.16
– ident: e_1_2_11_81_1
  doi: 10.1007/s00701-017-3325-7
– ident: e_1_2_11_66_1
  doi: 10.1111/papr.12406
– ident: e_1_2_11_10_1
  doi: 10.1067/moe.2001.115130
– ident: e_1_2_11_13_1
  doi: 10.1097/SCS.0000000000003481
– ident: e_1_2_11_88_1
  doi: 10.1016/j.wneu.2017.12.147
– ident: e_1_2_11_101_1
  doi: 10.1227/01.NEU.0000375491.81803.5D
– ident: e_1_2_11_80_1
  doi: 10.1016/j.jocn.2014.11.028
– ident: e_1_2_11_59_1
  doi: 10.1111/j.1600-0404.1970.tb05803.x
– ident: e_1_2_11_72_1
  doi: 10.1016/j.pain.2007.02.009
SSID ssj0002720
Score 2.6816347
SecondaryResourceType review_article
Snippet Background and purpose Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are...
Click here for the corresponding questions to this CME article.
Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different...
Background and purposeTrigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 831
SubjectTerms Baclofen
Botulinum toxin
Botulinum toxin type A
Carbamazepine
Decision making
Decompression
Diagnosis
Gabapentin
guideline
Guidelines
Intravenous administration
Intravenous infusion
Lamotrigine
Lidocaine
Literature reviews
Magnetic resonance imaging
Management
Medical imaging
Medical treatment
Microvasculature
Neuralgia
Neurology
NMR
Nuclear magnetic resonance
Nursing
Oxcarbazepine
Pain
Patients
Pharmacology
Phenytoin
Reflexes
Sequences
Surgery
Trigeminal nerve
trigeminal neuralgia
Title European Academy of Neurology guideline on trigeminal neuralgia
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.13950
https://www.ncbi.nlm.nih.gov/pubmed/30860637
https://www.proquest.com/docview/2216420978
https://www.proquest.com/docview/2190491746
Volume 26
WOSCitedRecordID wos000476944800004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 1468-1331
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002720
  issn: 1351-5101
  databaseCode: WIN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1468-1331
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002720
  issn: 1351-5101
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oJuKL90t1jig--FJps7Zp8UFENxRmEXG6t5Km6RiMTnYR_PeepBccKgi-tfSUhJxzku_L5QvAmcdwXJY0Ne2kRU3MRM9UKuQmMmZbeI70qD5f8dJlYej3-8HjElyWZ2FyfYhqwk1lhu6vVYLzePolybEruED4ovh6nWLcujWo3z51et2qI1ZLjJpvubapQq8QFlIbeaqfF4ejbxhzEbLqMaez8a_absJ6ATXJdR4bW7Aks21YfSgW03fgqpyJJ_km-Q8yTokW61Az7WQwVwpYaEnGGZkhiZf6_i-iFDD5aDDku9DrtJ9v7sziPgVTKJ09M0iQy3GHMc7dxA946rsCAVMiaeJRn6dMcsSHLUep4vlWLAJuJ7ZwEkt4MbqTtvaglo0zeQCECS-NA4QyvpJ6kBb3mbC4HSO7ShOXOQacl80aiUJsXN15MYpK0oENEukGMeC0Mn3LFTZ-MmqUvomKJJtGlCLXo-ogigEn1WdMD7XmwTM5nqMNAh4HKanjGbCf-7QqpYV0DhEaw8pq1_1efNQO2_rh8O-mR7CG4CrIt5U1oDabzOUxrIj32XA6acIy6_vNImLx7fU-_ARzWuqS
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD6MKeqL98u8RvHBl0qbdU0LgohsbLgVH7zsrWRpOgTpZBfBf-856QWHCoJvhZ6SkpOTfN9J8h2Ac0_guqx5YjlxnVsYiZ5FKuQWMmZHea72uLlf8dQVYej3-8F9Ba6KuzCZPkSZcKPIMPM1BTglpL9EOc4Fl4hfiLAvuAg0qHDDcycs52HaYTR0q-FYNPJyXSE6x1N-Or8afYOY84jVLDmttf_97Dqs5lCT3WRjYwMqOt2EpV6-mb4F10UmnmWH5D_YKGFGrIMy7Ww4IwUstGSjlE2RxGtT_4uRAqZ8Hb7IbXhsNR9u21ZeT8FSpLNnBTFyOekKIWUj9gOZ-A2FgCnWPPa4LxOhJeLDukuqeL49UIF0Yke5sa28AbqT13egmo5SvQdMKC8ZBAhlfJJ60Lb0hbKlM0B2lcQN4dbgoujXSOVi41Tz4jUqSAd2SGQ6pAZnpelbprDxk9Fh4ZwoD7JJxDlyPU4XUWpwWr7G8KA9D5nq0QxtEPC4SEldrwa7mVPLVupI5xChCfxZ47vfm4-aYdM87P_d9ASW2w-9btTthHcHsIJAK8iOmB1CdTqe6SNYVO_Tl8n42AzbT7VI610
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7IlOGL98t0ahQffKm0Wde0IIi4DcU5RFR8K1mSDkG6sYvgv_ec9IKiguBboSck5OQk35fLdwCOA4HrsuGJ4-kGdzASA4dUyB1kzJ4KfBNw-77iqSt6vfD5Obqbg7PiLUymD1FuuFFk2PmaAtyMdPIpynEuOEX8QoR93qckMhWYb913HrvlTExnjJZwNT2Hxl6uLEQ3ecrCX9ejbyDzK2a1i05n-X_NXYGlHGyyi2x0rMKcSdegepsfp6_DebEXz7Jr8u9smDAr10F77WwwIw0stGTDlE2RxhubAYyRBqZ8HbzIDXjstB8ur5w8o4KjSGnPiTSyOekLIWVTh5FMwqZCyKQN1wEPZSKMRITY8EkXL3T7KpKe9pSvXRX00aG8sQmVdJiabWBCBUk_QjATktiDcWUolCu9PvKrRDeFX4OTol9jlcuNU9aL17igHdghse2QGhyVpqNMY-Mno3rhnDgPs0nMObI9Tk9RanBY_sYAoVMPmZrhDG0Q8vhISv2gBluZU8taGkjoEKMJbKz13e_Vx-1e237s_N30AKp3rU7cve7d7MIiIq0ou2NWh8p0PDN7sKDepi-T8X4-bj8AIonsBg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=European+Academy+of+Neurology+guideline+on+trigeminal+neuralgia&rft.jtitle=European+journal+of+neurology&rft.au=Bendtsen%2C+L.&rft.au=Zakrzewska%2C+J.+M.&rft.au=Abbott%2C+J.&rft.au=Braschinsky%2C+M.&rft.date=2019-06-01&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=26&rft.issue=6&rft.spage=831&rft.epage=849&rft_id=info:doi/10.1111%2Fene.13950&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_ene_13950
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon